Opportunity Information: Apply for PA 18 045
The government grant opportunity titled "Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)" (Funding Opportunity Number PA-18-045) is a discretionary NIH research grant designed to stimulate innovative, early-stage work on puberty and the broader trajectory of sexual development during adolescence. Its central goal is to encourage strong, creative applications that can close major scientific gaps in how normative (typical) sexual maturation unfolds in both males and females, and how that maturation leads to the establishment of reproductive competence. The announcement emphasizes that progress in this field will likely require new technologies, novel measurement strategies, and fresh conceptual approaches, suggesting an interest in projects that move beyond traditional methods and bring sharper biological, behavioral, and developmental resolution to the study of pubertal change.
The FOA is positioned around the idea that adolescence is a complex reproductive transition rather than a single event, and that the field still lacks sufficiently detailed, real-world characterization of that transition across individuals and over time. Supported studies are expected to advance foundational knowledge about pubertal timing and tempo, the sequencing of developmental milestones, and the interacting hormonal, physiological, and developmental processes that underpin sexual maturation. Because it uses the NIH R21 mechanism, the opportunity is especially aligned with exploratory or developmental research that can generate high-value preliminary data, test emerging tools, or establish proof-of-concept findings that could later support larger-scale projects. The "Clinical Trial Optional" designation indicates that applicants may propose clinical trials if appropriate, but are not required to do so; non-trial mechanistic, observational, or methodological work fits as well, as long as it meaningfully addresses the scientific aims around puberty and adolescent reproductive development.
Administratively, this is a grant (Funding Instrument Type: Grant) within the Health, Income Security and Social Services activity area, listed under CFDA 93.865 and administered by the National Institutes of Health. The source information lists an award ceiling of $200,000, reflecting the typical smaller, exploratory scope of R21 projects. The original closing date provided is 2019-09-07, and the FOA creation date is 2017-11-03. While the record does not specify the number of expected awards, the emphasis is clearly on funding standout projects that can push the science forward through methodological innovation and strong developmental framing.
Eligibility is broad and inclusive, spanning many types of domestic and non-domestic institutions and organizations. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (outside higher education); for-profit organizations (other than small businesses) as well as small businesses; and other applicant types. In addition, the FOA explicitly highlights several categories of "other eligible applicants" to encourage participation by diverse institutions and communities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations), as well as Indian/Native American tribal governments that are not federally recognized. Taken together, that list signals an intent to broaden the research base and support work that may involve varied populations, settings, and collaborative structures, provided the science directly advances understanding of the adolescent reproductive transition.
In practical terms, a competitive application under this FOA would be expected to articulate a clear, impactful research question tied to the normative biology and developmental course of puberty, justify why current knowledge is insufficient, and explain how the proposed approach improves on existing tools or frameworks. The announcement strongly implies that applications using cutting-edge measurement (for example, improved hormonal profiling, wearable or remote monitoring strategies, new analytic techniques for developmental trajectories, or refined phenotyping of pubertal milestones) are particularly relevant, as long as they are used to deepen understanding of how reproductive maturation is established across adolescence in both sexes. The intended payoff is not just descriptive detail for its own sake, but a stronger scientific foundation for understanding typical development, which can later support better identification of atypical patterns, risk states, and targets for future interventions.Apply for PA 18 045
- The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865.
- This funding opportunity was created on 2017-11-03.
- Applicants must submit their applications by 2019-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PA-18-045.
What type of award is this?
This is a grant, using the NIH R21 mechanism (exploratory/developmental research).
What agency administers this opportunity?
This opportunity is administered by the National Institutes of Health (NIH).
What is the main scientific focus of the FOA?
The FOA supports innovative, early-stage research on puberty and the broader trajectory of sexual development during adolescence, with an emphasis on characterizing how normative (typical) sexual maturation unfolds in both males and females and how it leads to the establishment of reproductive competence.
How does the FOA frame adolescence and puberty?
The announcement frames adolescence as a complex reproductive transition rather than a single event. It emphasizes that the field needs more detailed, real-world characterization of that transition across individuals and over time.
What kinds of knowledge gaps is this FOA trying to address?
The FOA is aimed at closing major scientific gaps in understanding the normative biology and developmental course of puberty, including pubertal timing and tempo, sequencing of developmental milestones, and interacting hormonal, physiological, and developmental processes that underpin sexual maturation.
Is this opportunity intended for early-stage or exploratory projects?
Yes. Because it uses the NIH R21 mechanism, it is especially aligned with exploratory or developmental research that can generate high-value preliminary data, test emerging tools, or establish proof-of-concept findings that may support larger-scale projects later.
Are clinical trials required?
No. The FOA is designated "Clinical Trial Optional," meaning applicants may propose clinical trials if appropriate, but they are not required to do so.
Are non-clinical-trial studies allowed?
Yes. The FOA indicates that non-trial mechanistic, observational, or methodological work can fit, as long as the study meaningfully addresses the scientific aims related to puberty and adolescent reproductive development.
What kinds of approaches does the FOA encourage?
The announcement suggests that progress will likely require new technologies, novel measurement strategies, and fresh conceptual approaches. It implies strong interest in projects that go beyond traditional methods and bring sharper biological, behavioral, and developmental resolution to the study of pubertal change.
Does the FOA encourage new measurement or technology development?
Yes. The FOA strongly implies that applications using cutting-edge measurement and refined characterization strategies are particularly relevant, when they deepen understanding of reproductive maturation across adolescence in both sexes.
What examples of "cutting-edge measurement" are mentioned or implied?
The FOA description highlights examples such as improved hormonal profiling, wearable or remote monitoring strategies, new analytic techniques for developmental trajectories, and refined phenotyping of pubertal milestones, provided they are used to advance understanding of normative adolescent reproductive development.
What outcomes or deliverables is the FOA aiming for?
The intended payoff is a stronger scientific foundation for understanding typical development. The FOA emphasizes that the goal is not descriptive detail for its own sake, but foundational knowledge that can later support better identification of atypical patterns, risk states, and targets for future interventions.
Does the FOA focus on both males and females?
Yes. The central goal includes understanding how normative sexual maturation unfolds in both males and females and how reproductive competence is established.
What is the activity area listed for this opportunity?
The opportunity is listed under the Health, Income Security and Social Services activity area.
What is the CFDA number for this grant?
The CFDA listing provided is 93.865.
What is the award ceiling?
The source information lists an award ceiling of $200,000, consistent with the smaller, exploratory scope typical of R21 projects.
How many awards will NIH make under this FOA?
The record provided does not specify the number of expected awards.
What is the original closing date listed for this opportunity?
The original closing date provided is 2019-09-07.
When was this FOA created?
The FOA creation date provided is 2017-11-03.
Who is eligible to apply?
Eligibility is broad and includes many domestic and non-domestic institutions and organizations, including various levels of government, higher education institutions (public and private), tribal governments and tribal organizations, nonprofits (with and without 501(c)(3) status, outside higher education), for-profit organizations (including small businesses), public housing authorities, and other applicant types listed in the FOA summary.
Are state, county, or local governments eligible?
Yes. Eligible applicants include state governments, county governments, city or township governments, and special district governments.
Are schools and universities eligible?
Yes. Eligible applicants include independent school districts and both public/state-controlled and private institutions of higher education.
Are tribal entities eligible?
Yes. Eligible applicants include federally recognized Native American tribal governments, tribal organizations other than federally recognized governments, and Indian/Native American tribal governments that are not federally recognized.
Are nonprofits eligible?
Yes. Nonprofits with and without 501(c)(3) status (outside higher education) are eligible.
Are for-profit organizations eligible?
Yes. For-profit organizations (other than small businesses) and small businesses are listed as eligible applicants.
Are U.S. territories or possessions eligible?
Yes. The FOA explicitly includes U.S. territories or possessions among "other eligible applicants."
Are non-U.S. entities (foreign organizations) eligible?
Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) among "other eligible applicants."
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly highlights faith-based or community-based organizations among "other eligible applicants."
Are minority-serving institutions specifically encouraged to apply?
Yes. The FOA explicitly highlights Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs) among "other eligible applicants."
Are federal agencies eligible to apply?
Yes. The FOA lists eligible federal agencies among "other eligible applicants."
What would a competitive application be expected to include?
Based on the summary provided, a competitive application would be expected to (1) articulate a clear, impactful research question tied to the normative biology and developmental course of puberty, (2) justify why current knowledge is insufficient, and (3) explain how the proposed approach improves on existing tools or frameworks, particularly through innovation in measurement, technology, or conceptualization.
Is the FOA focused on normative development or atypical development?
The FOA is centered on normative (typical) sexual maturation and the establishment of reproductive competence. It notes that strengthening the foundation of knowledge about typical development can later support improved identification of atypical patterns and risk states.
Does the FOA emphasize studying change over time?
Yes. The summary emphasizes characterization of the adolescent reproductive transition across individuals and over time, including timing, tempo, sequencing, and interacting biological and developmental processes.
Browse more opportunities from the same category: Health, Income Security and Social Services
Next opportunity: Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Human Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to CNS Small Blood and Lymphatic Vessels (R01)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 045
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 045) also looked into and applied for these:
| Funding Opportunity |
|---|
| Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional) Apply for PA 18 046 Funding Number: PA 18 046 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional) Apply for PA 18 044 Funding Number: PA 18 044 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Academic Research Enhancement Award (R15 Clinical Trial Required) Apply for PA 18 343 Funding Number: PA 18 343 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $300,000 |
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional) Apply for PAR 18 091 Funding Number: PAR 18 091 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional) Apply for PAR 18 094 Funding Number: PAR 18 094 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional) Apply for PA 18 089 Funding Number: PA 18 089 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional) Apply for PA 18 096 Funding Number: PA 18 096 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42) Apply for RFA HD 18 034 Funding Number: RFA HD 18 034 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional) Apply for PAR 18 095 Funding Number: PAR 18 095 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $50,000 |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) Apply for RFA HD 18 033 Funding Number: RFA HD 18 033 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Contraception Research Centers Program (U54) Apply for RFA HD 18 035 Funding Number: RFA HD 18 035 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Trophoblast Differentiation and Function (R21 Clinical Trial Optional) Apply for PA 18 047 Funding Number: PA 18 047 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional) Apply for PA 18 048 Funding Number: PA 18 048 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21 Clinical Trial Optional) Apply for PA 18 093 Funding Number: PA 18 093 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| NCMRR Early Career Research Award (R03 Clinical Trial Optional) Apply for PAR 18 211 Funding Number: PAR 18 211 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $100,000 |
| Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) Apply for PAR 18 213 Funding Number: PAR 18 213 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44) Apply for RFA HD 18 102 Funding Number: RFA HD 18 102 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42) Apply for RFA HD 18 101 Funding Number: RFA HD 18 101 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional) Apply for PAR 18 214 Funding Number: PAR 18 214 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $200,000 |
| Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional) Apply for PAR 18 215 Funding Number: PAR 18 215 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 045", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
